The use of dosage levels appropriate to the nature of the disease and the correct method of administration are essential to achieve optimal effect.
In the acute stage of stroke (acute cerebrovascular accident) - hemorrhagic (caused by rupture of cerebral vessels) and ischemic (caused by insufficient blood flow); in severe forms of meningitis (purulent inflammation of the membranes of the brain), encephalitis immediately after severe traumatic brain injury and neurosurgical operations (depending on the degree of depression of consciousness) Cerebrolysin should be administered intravenously every 10-30 ml per 100-200 ml of isotonic sodium chloride solution in within 60-90 minutes. For this category of patients, Cerebrolysin is prescribed for 10-25 days. The inclusion of the drug, a complex of therapeutic measures in these clinical situations contributes to a more rapid regression (reverse development) of impaired consciousness and a clear reduction (or elimination) of a neurological defect, as well as the normalization of EEG characteristics (electroencephalograms - characteristics of the electrical activity of the brain).
In the residual period of stroke (residual manifestations after acute cerebrovascular accident), severe forms of neuroinfections (infectious diseases of the central nervous system) and brain injuries, Cerebrolysin is injected intravenously with a jet stream of 5-10 ml daily for 20-30 days. If necessary, a course of treatment of the same duration can be repeated after 3-4 months. In these pathological conditions, under the influence of cerebrolysin, vital activity is restored faster and more completely, changes in EEG characteristics regress (decrease). In milder cases, the drug is administered intramuscularly in a dose of 1-2 ml. The course of treatment is 20-30 injections.
The appointment of Cerebrolysin is effective in the initial forms of cerebrovascular pathology (due to changes in the vessels of the brain), as well as in discirculatory encephalopathy (brain disease due to chronic cerebrovascular accident). The results of using the drug are characterized by a decrease in asthenic syndrome (a general decrease in the functional activity of the body) and an increase in efficiency, but the degree of effectiveness largely depends on the severity of cerebrovascular disorders. In these cases, the drug is prescribed intramuscularly in a dose of 1-2 ml. The course is 20-30 injections.
In psychiatry, Cerebrolysin is successfully used for psychoorganic syndrome. Enter 5-10 ml intravenously. The course of treatment is 20-25 injections.
The appointment of Cerebrolysin is one of the most effective measures to compensate for a mental defect in dementia of various origins (dementia of various origins). Intravenous drip of 10-20 ml of the drug in 100-250 ml of isotonic sodium chloride solution (course of treatment - 20-30 injections) can achieve a temporary regression of memory and attention disorders, improve daily vital functions. Therefore, in dementia, the appointment of repeated courses of treatment with Cerebrolysin is indicated.
With endogenous depression (depressive state due to mental illness), resistant to antidepressants (antidepressant drugs that cannot be treated), the patient's condition usually improves after 10-15 intravenous injections (5 ml each). After sessions of electroconvulsive and insulin shock therapy, the mental activity of patients is restored after 3-5 intravenous droppers of 10-15 ml of the drug in 100-250 ml of isotonic sodium chloride solution. For children with mental retardation, the drug is prescribed intramuscularly, 1-2 ml daily for a month. Such courses can be repeated 2-3 times a year. With a moderate degree of mental defect, its use is preferable.
